Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pietz, J.
Right arrow Articles by Boesch, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pietz, J.
Right arrow Articles by Boesch, C.

Radiology, Vol 201, 413-420, Copyright © 1996 by Radiological Society of North America


ARTICLES

Phenylketonuria: findings at MR imaging and localized in vivo H-1 MR spectroscopy of the brain in patients with early treatment

J Pietz, R Kreis, H Schmidt, UK Meyding-Lamade, A Rupp and C Boesch
Department of Pediatric Neurology, University of Heidelberg, Germany.

PURPOSE: To characterize white matter changes in early-treated phenylketonuria (PKU) with magnetic resonance (MR) imaging and hydrogen- 1 MR spectroscopy and to correlate these findings to biochemical control and brain function. MATERIALS AND METHODS: Fifty-one patients aged 12-33 years underwent T1-, T2-, and proton-density-weighted MR imaging and testing of intelligence, visual evoked potentials (VEPs), and neuropsychologic status (29 adult patients only). H-1 MR spectroscopy was performed in eight patients to determine brain metabolite concentrations, including phenylalanine (PHE) concentration, and brain compartmentation. RESULTS: MR imaging revealed a high frequency of supra- and infratentorial abnormalities. MR imaging grade, which was based on areas of high signal intensity on T2-weighted images, showed statistically significant correlation with long-term biochemical control and neuropsychologic test results but not with intelligence quotient or VEPs. H-1 MR spectroscopy revealed normal metabolite levels, except for increased PHE levels. It also showed enlarged cerebrospinal fluid-like compartments in affected white matter, related to plasma and brain concentrations of PHE and MR imaging grades. CONCLUSION: A synergistic use of MR imaging and MR spectroscopy may help elucidate both the pathogenesis of brain dysfunction and clinical treatment policies in PKU.


This article has been cited by other articles:


Home page
Arch. Dis. Child.Home page
S. Channon, G. Goodman, S. Zlotowitz, C. Mockler, and P. J Lee
Effects of dietary management of phenylketonuria on long-term cognitive outcome
Arch. Dis. Child., March 1, 2007; 92(3): 213 - 218.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
S. M. Sirrs, C. Laule, B. Madler, E. E. Brief, S. A. Tahir, C. Bishop, and A. L. MacKay
Normal-appearing White Matter in Patients with Phenylketonuria: Water Content, Myelin Water Fraction, and Metabolite Concentrations
Radiology, January 1, 2007; 242(1): 236 - 243.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
B. Perez-Duenas, J. Pujol, C. Soriano-Mas, H. Ortiz, R. Artuch, M. A. Vilaseca, and J. Campistol
Global and regional volume changes in the brains of patients with phenylketonuria
Neurology, April 11, 2006; 66(7): 1074 - 1078.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
N. H. Pfaendner, G. Reuner, J. Pietz, G. Jost, D. Rating, V. A. Magnotta, A. Mohr, B. Kress, K. Sartor, and S. Hahnel
MR Imaging-Based Volumetry in Patients with Early-Treated Phenylketonuria
AJNR Am. J. Neuroradiol., August 1, 2005; 26(7): 1681 - 1685.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
K. Kono, Y. Okano, K. Nakayama, Y. Hase, S. Minamikawa, N. Ozawa, H. Yokote, and Y. Inoue
Diffusion-weighted MR Imaging in Patients with Phenylketonuria: Relationship between Serum Phenylalanine Levels and ADC Values in Cerebral White Matter
Radiology, August 1, 2005; 236(2): 630 - 636.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
S. S.-F. Peng, W.-Y. I. Tseng, Y.-H. Chien, W.-L. Hwu, and H.-M. Liu
Diffusion Tensor Images in Children with Early-Treated, Chronic, Malignant Phenylketonuric: Correlation with Intelligence Assessment
AJNR Am. J. Neuroradiol., October 1, 2004; 25(9): 1569 - 1574.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
R. Matalon, S. Surendran, K. M. Matalon, S. Tyring, M. Quast, W. Jinga, E. Ezell, and S. Szucs
Future Role of Large Neutral Amino Acids in Transport of Phenylalanine Into the Brain
Pediatrics, December 1, 2003; 112(6): 1570 - 1574.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
H. E. Moller, J. Weglage, U. Bick, D. Wiedermann, R. Feldmann, and K. Ullrich
Brain Imaging and Proton Magnetic Resonance Spectroscopy in Patients With Phenylketonuria
Pediatrics, December 1, 2003; 112(6): 1580 - 1583.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
Y.-H. Chien, S.-F. Peng, T.-R. Wang, and W.-L. Hwu
Cranial MR Spectroscopy of Tetrahydrobiopterin Deficiency
AJNR Am. J. Neuroradiol., April 1, 2002; 23(6): 1055 - 1058.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
M. D. Phillips, P. McGraw, M. J. Lowe, V. P. Mathews, and B. E. Hainline
Diffusion-Weighted Imaging of White Matter Abnormalities in Patients with Phenylketonuria
AJNR Am. J. Neuroradiol., September 1, 2001; 22(8): 1583 - 1586.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
R. Koch, R. Moats, F. Guttler, P. Guldberg, and M. Nelson Jr.
Blood-Brain Phenylalanine Relationships in Persons With Phenylketonuria
Pediatrics, November 1, 2000; 106(5): 1093 - 1096.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1996 by the Radiological Society of North America.